Phospholamban and cardiac contractile function.

[1]  Mark A Sussman,et al.  Re-evaluating sarcoplasmic reticulum function in heart failure , 2000, Nature Medicine.

[2]  H. Fechner,et al.  Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. , 2000, Circulation.

[3]  A. Mattiazzi,et al.  cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts. , 1990, The American journal of physiology.

[4]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[5]  I. Grupp,et al.  The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions. , 1999, Journal of molecular and cellular cardiology.

[6]  M. Kirchberger,et al.  Effects of adenosine 3':5'-monophosphate-dependent protein kinase on sarcoplasmic reticulum isolated from cardiac and slow and fast contracting skeletal muscles. , 1976, The Journal of biological chemistry.

[7]  I. Grupp,et al.  Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. , 1998, Circulation research.

[8]  R. Schwinger,et al.  Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban Phoshorylation , 1999 .

[9]  É. Kiss,et al.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.

[10]  B. Hoit,et al.  Cardiac-specific Overexpression of a Superinhibitory Pentameric Phospholamban Mutant Enhances Inhibition of Cardiac Functionin Vivo * , 2000, The Journal of Biological Chemistry.

[11]  D. Hathaway,et al.  beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. , 1983, The Journal of biological chemistry.

[12]  J. Lorenz,et al.  Regulatory effects of phospholamban on cardiac function in intact mice. , 1997, American journal of physiology. Heart and circulatory physiology.

[13]  Ha Won Kim,et al.  Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles. , 1990, The Journal of biological chemistry.

[14]  D. Bers,et al.  Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. , 2000, American journal of physiology. Heart and circulatory physiology.

[15]  L. Jones,et al.  Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits. , 1984, The Journal of biological chemistry.

[16]  E. Kranias,et al.  Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+. , 1996, The American journal of physiology.

[17]  Yvonne M. Kobayashi,et al.  A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore Structure (*) , 1996, The Journal of Biological Chemistry.

[18]  I. Klein,et al.  Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. , 2000, Endocrinology.

[19]  D. Maclennan,et al.  Phospholamban Regulates the Ca2+-ATPase through Intramembrane Interactions* , 1996, The Journal of Biological Chemistry.

[20]  E. Kranias,et al.  Phospholamban: a prominent regulator of myocardial contractility. , 1996, Circulation research.

[21]  B. Hoit,et al.  The Transgenic Expression of Highly Inhibitory Monomeric Forms of Phospholamban in Mouse Heart Impairs Cardiac Contractility* , 2000, The Journal of Biological Chemistry.

[22]  A. Mattiazzi,et al.  Immunodetection of Phosphorylation Sites Gives New Insights into the Mechanisms Underlying Phospholamban Phosphorylation in the Intact Heart* , 1996, The Journal of Biological Chemistry.

[23]  T. Toyofuku,et al.  Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca(2+)-ATPase of sarcoplasmic reticulum. , 1994, The Journal of biological chemistry.

[24]  J. Guerrero,et al.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Walsh,et al.  In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.

[26]  D. Maclennan,et al.  Phospholamban Domain Ib Mutations Influence Functional Interactions with the Ca2+-ATPase Isoform of Cardiac Sarcoplasmic Reticulum* , 1998, The Journal of Biological Chemistry.

[27]  Andrew N. Carr,et al.  Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban* , 2000, The Journal of Biological Chemistry.

[28]  M. Olivari,et al.  Altered calcium uptake by the sarcoplasmic reticulum following cardiac transplantation in humans. , 1987, The Canadian journal of cardiology.

[29]  W. Lew,et al.  Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility. , 1999, Circulation.

[30]  I. Édes,et al.  Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts. , 1993, The American journal of physiology.

[31]  E. Carafoli,et al.  Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum , 1989, Nature.

[32]  M. Böhm,et al.  Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. , 1995, Circulation.

[33]  G. Dorn,et al.  Monomeric phospholamban overexpression in transgenic mouse hearts. , 1997, Circulation research.

[34]  G. Dorn,et al.  Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. , 1996, The Journal of clinical investigation.

[35]  U. Schmidt,et al.  Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. , 1997, Circulation research.

[36]  E. Kranias,et al.  A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.

[37]  U. Schmidt,et al.  Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban. , 1999, American journal of physiology. Heart and circulatory physiology.

[38]  Heping Cheng,et al.  Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[39]  I. Sjaastad,et al.  Thyroid hormone control of contraction and the Ca(2+)-ATPase/phospholamban complex in adult rat ventricular myocytes. , 1999, Journal of molecular and cellular cardiology.

[40]  D. Maclennan,et al.  Phospholamban Inhibitory Function Is Activated by Depolymerization* , 1997, The Journal of Biological Chemistry.

[41]  E. Kranias,et al.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. , 1988, The Biochemical journal.

[42]  W Grossman,et al.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. , 1987, Circulation research.

[43]  N. Alpert,et al.  Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. , 1991, Circulation research.

[44]  D. Engelman,et al.  Structural organization of the pentameric transmembrane alpha‐helices of phospholamban, a cardiac ion channel. , 1994, The EMBO journal.

[45]  L. Jones,et al.  Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase. , 1992, The Journal of biological chemistry.

[46]  J. Slack,et al.  Phospholamban gene dosage effects in the mammalian heart. , 1996, Circulation research.

[47]  D. Dobrev,et al.  Regulation of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban in the failing and nonfailing heart. , 2000, Cardiovascular research.

[48]  R. Adelstein,et al.  Phosphorylation of phospholamban by calcium-activated, phospholipid-dependent protein kinase. Stimulation of cardiac sarcoplasmic reticulum calcium uptake. , 1984, The Journal of biological chemistry.

[49]  E. Kranias,et al.  Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation* , 1998, The Journal of Biological Chemistry.

[50]  T. Doetschman,et al.  Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. , 1994, Circulation research.

[51]  L. Jones,et al.  Functional Co-expression of the Canine Cardiac Ca2+Pump and Phospholamban in Spodoptera frugiperda (Sf21) Cells Reveals New Insights on ATPase Regulation* , 1997, The Journal of Biological Chemistry.

[52]  F. Green,et al.  Autonomic regulation of type 1 protein phosphatase in cardiac muscle. , 1989, The Journal of biological chemistry.

[53]  E. Kranias,et al.  Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice. , 1999, Circulation research.

[54]  K. Otsu,et al.  Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression. , 1994, Journal of molecular and cellular cardiology.

[55]  A. M. Watanabe,et al.  Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms. , 1985, The Journal of biological chemistry.

[56]  L. Raeymaekers,et al.  Effects of cyclic nucleotide dependent protein kinases on the endoplasmic reticulum Ca2+ pump of bovine pulmonary artery. , 1990, Cell calcium.

[57]  D. D. Thomas,et al.  Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. , 1999, Biochemistry.

[58]  U. Schmidt,et al.  Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. , 1999, Circulation.

[59]  E. Kranias.  Regulation of Ca2+ transport by cyclic 3',5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. , 1985, Biochimica et biophysica acta.

[60]  S. Liggett,et al.  beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts. , 1997, The American journal of physiology.

[61]  W. Schmitz,et al.  Increased expression of cardiac phosphatases in patients with end-stage heart failure. , 1997, Journal of molecular and cellular cardiology.

[62]  K. Mikoshiba,et al.  Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. , 1995, Circulation.

[63]  L. Jones,et al.  Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. , 1989, The Journal of biological chemistry.

[64]  J. H. Collins,et al.  Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.

[65]  S. Daniels,et al.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice. , 1999, The American journal of pathology.

[66]  S. Kakiuchi,et al.  Effects of phospholamban phosphorylation catalyzed by adenosine 3':5'-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. , 1983, Journal of molecular and cellular cardiology.

[67]  D. D. Thomas,et al.  Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. , 1997, Biochemistry.